ICAHN ENTERPRISES L.P.

Icahn Enterprises L.P. filed an investor presentation providing a comprehensive business update, including financial performance for the twelve months ended March 31, 2026, and its balance sheet as of that date. The company reported an Adjusted EBITDA attributable to IEP of $206 million and a Net Loss attributable to IEP of $336 million for the LTM period. Its Indicative Net Asset Value stood at $3.37 billion as of March 31, 2026, with total assets of $12.93 billion. The presentation also detailed segment performance and strategic initiatives across its diversified holdings, and noted a change in Adjusted EBITDA calculation effective March 31, 2026.

Icahn Enterprises reported a net loss attributable to the company of $(459)M for Q1 2026, an increase from $(422)M in Q1 2025, though basic and diluted loss per LP unit improved to $(0.71) from $(0.79). Net sales rose to $2,311M from $2,002M year-over-year, and net cash provided by operating activities significantly improved to $397M from a $(182)M use. The company's total equity decreased to $2,347M, and the fair value of its Investment Funds declined to $2.2B. Strategic moves included the completion of Viskase's merger with Enzon Pharmaceuticals, Inc., and an increased ownership stake in CVR Energy to approximately 71%.

Icahn Enterprises L.P. reported a net loss attributable to IEP of $459 million, or $0.71 per depositary unit, for the first quarter of 2026, compared to a net loss of $422 million in Q1 2025. Revenues increased to $2.2 billion from $1.9 billion year-over-year. The company's indicative net asset value rose to approximately $3.4 billion as of March 31, 2026, an increase of $201 million from the prior quarter. Additionally, a quarterly distribution of $0.50 per depositary unit was declared.